Take cancer from uncertainty to insight
CGP offers a streamlined, faster method for gaining insights into the genomic underpinnings of cancer. With proven solutions and world-class support, the Illumina TruSight Oncology 500
portfolio is ready to enable your CGP efforts. Illumina is committed to investing in the TruSight Oncology 500 portfolio to bring new advancements to oncology researchers.
Together, we can obtain a greater understanding of the genome, propelling precision medicine forward.
Visit www.illumina.com/tso500 or contact us today
We are always available for questions, insights, and conversatiotechsupport@illumina.comumina.com.
1.800.809.4566 toll-free (US) | +1.858.202.4566 tel
techsupport@illumina.com | www.illumina.com
© 2023 Illumina, Inc. All rights reserved. All trademarks are the property of Illumina, Inc. or their
respective owners. For specific trademark information, see www.illumina.com/company/
legal.html.
For Research Use Only. Not for use in diagnostic procedures.
CAP-Number